Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Rebecca Panks

  • Home
  • Author: Rebecca Panks

Synairgen shows promising results for inhaled COVID-19 treatment but additional data needed to understand role in treatment, says GlobalData

Following the news that UK biotech Synairgen announced reductions in COVID-19 disease progression and increased rates of recovery relative to placebo; Michael Breen, PhD, Director of Infectious Diseases and Ophthalmology at GlobalData, a leading data and analytics company, offers his view: “Synairgen’s inhaled interferon (IFN)-β is now one of a select few drugs having shown […]
Read more

Abbott Laboratories feels optimistic about recovery in cardiovascular device market amid major losses halfway through 2020, says GlobalData

Following the news that procedure volumes with Abbott Laboratories’ cardiovascular devices have recovered to approximately 90% of pre-COVID-19 volumes; Richard Hyde, Medical Analyst at GlobalData, a leading data and analytics company, offers his view on the subject: “Abbott Laboratories is one of the highest performing medical device companies in the COVID-19 era and ranks second […]
Read more
,

Nestlé’s D2C sales strategy could boost customer loyalty post-COVID-19, says GlobalData

Nestlé’s direct-to-consumer sales strategy, beginning in Spain this week, could be an opportunity for the brand to profit from lockdown and pre-empt future market disruptions, allowing the company to sell its products without the influence of retailer relationships. If the move is successful, other brands may also follow suit as providing convenience during the pandemic […]
Read more

CanSino first with Phase II COVID-19 vaccine results, but one shot might not be enough, says GlobalData

Following the news that Chinese biotech CanSino published Phase II results of its COVID-19 vaccine candidate Ad5-nCoV; Philipp Rosenbaum, PhD, Senior Infectious Diseases Analyst at GlobalData, a leading data and analytics company, offers his view: “With one dose, CanSino’s human adenovirus vector-based vaccine elicited receptor-binding and neutralizing antibodies in 508 patients peaking after 28 days. […]
Read more

Sample pooling to accelerate COVID-19 testing, says GlobalData

Following the news that Quest Diagnostics received emergency use authorization (EUA) from the Food and Drug Administration (FDA) for its sample pooling-based COVID-19 test; Brian Hicks, Medical Devices Analyst at GlobalData, a leading data and analytics company, offers his view: “At a time when more COVID-19 tests are being conducted, yet negative results are generally […]
Read more

AstraZeneca/Oxford University’s vaccine shows solid safety results in Phase I/II in increasingly crowded field of vaccine candidates, says GlobalData

Following the news that AstraZeneca and Oxford University published Phase I/II results of their COVID-19 vaccine candidate ChAdOx1/AZD1222; Philipp Rosenbaum, PhD, Senior Infectious Diseases Analyst and Michael Breen, PhD, Director of Infectious Diseases at GlobalData, a leading data and analytics company, offer their view: Rosenbaum commented “The vaccine developed by Oxford University in collaboration with […]
Read more

US hospitals alone purchase $94m PPE in H1 2020 – GlobalData considers latest N95 mask prototype developed by Boston researchers

In the first half of 2020, hospitals in US alone have purchased $94m of PPE, according to GlobalData, a leading data and analytics company. Additionally, numerous countries around the world have passed laws making face masks mandatory in public places, increasing the demand even further. GlobalData expects the US PPE market to grow at an […]
Read more

Cadbury’s smaller-size, same-price announcement won’t fly with consumers’ budgets, says GlobalData

Following the news that some of Cadbury’s multipack chocolate bars will get smaller but costs will stay the same by 2021; Yamina Tsalamlal, Consumer Analyst at GlobalData offers her view: “Following ‘Watergate’, and ‘Deflate-Gate’ comes the latest in the series of ‘-gate’ scandals with ‘Shrinkflation-Gate’. It might seem like a small change from Cadbury’s perspective, […]
Read more

Prioritized rollout required for COVID-19 vaccine to achieve 75% population vaccinated for herd immunity to be effective, says GlobalData

As a vaccine product passes through clinical development, manufacturers will have to ensure that they are taking the required steps to ramp up production, as there is unprecedented global demand. The quick manufacture and distribution of effective vaccine products are vital, as a slow or botched rollout may lead to global unrest due to the […]
Read more

Giving in to governmental pressure and approving sub-par vaccine may dissuade further innovation, says GlobalData

There are indications that some companies may be expediting the approval of COVID-19 vaccines, sometimes with subpar effectiveness, in response to pressure from governmental organizations. The approval of such vaccines may display short-term benefits, however, it will dissuade other companies and institutes from developing more effective vaccines if a significant proportion of the population has […]
Read more

Eli Lilly’s and Regeneron’s COVID-19 mAbs spark interest as monotherapies along with potential as cocktails for treatment and post-exposure prevention, says GlobalData

COVID-19 research and development (R&D) has started to see the first set of novel drug candidates enter clinical trials by way of monoclonal antibodies (mAbs). Experts interviewed by GlobalData see potential in these but are cautious that the cocktail strategy may not pan out better than treating with a single mAb, according to reporting from […]
Read more
,

Passing on VAT savings may offer lifeline to large foodservice players by offering respite to families and promoting ‘affordable luxury’, says GlobalData

Following the news that Starbucks and McDonald’s has promised price reductions after the UK Government’s announcement to cut VAT in the hospitality industry from 20% to 5%; Yamina Tsalamlal, Consumer Analyst at GlobalData, a leading data and analytics company, offers her view: “To the quarter (23%) of UK consumers saying they are extremely concerned about […]
Read more

Qantas Airbus A380 grounding points to expected U-shaped commercial aviation recovery, says GlobalData

Following the news that major airline Qantas is grounding and preserving its Airbus A380 fleet for at least three years until the passenger market starts to rebound; Anthony Endresen, Aerospace and Defense Analyst at GlobalData, a leading data and analytics company, offers his view on the situation: “The commercial aviation sector looks set for a […]
Read more
1 … 46 47 48 49 50 … 77